ERBB2 and breast carcinoma: Studies have shown that ERBB2 relies on HIF-1 to promote breast cancer growth in vivo, enhancing the adaptability of tumor cells to hypoxic environments through HIF-1-mediated signaling pathways, thereby generating oxygen resistance (47).